According to recent statistics, millions of Americans use semaglutide and similar injectable medications for weight loss
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome
As oral GLP-1 medications become more widely accessible, well integrate them thoughtfully into our programs, always prioritizing what works best for your lifestyle and goals
As health services researchers studying prescription medication safety, we are highly concerned about the risks of online advertisements selling alternative versions of GLP-1 weight loss medications
For blood glucose control in patients with type 2 diabetes, initial effects can often be observed within the first 1-2 weeks of treatment as the medication begins influencing insulin and glucagon secretion
The goal is to use enough medication to support meaningful clinical improvement while preserving nutrition, muscle, function, and long-term adherence
